Polar Asset Management Partners Inc. Xenon Pharmaceuticals Inc. Transaction History

Polar Asset Management Partners Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $1.16 Million - $1.61 Million	45,700 Added 58.37%	124,000 $3.77 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $1.22 Million - $2.77 Million	78,300 New	78,300 $2.45 Million

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.